menu
    • menu

    Company profile for Vaderis Therapeutics

    NEW Drugs in Dev: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vaderis is a clinical stage biotechnology company focussed on the treatment of rare and orphan diseases caused by Vascular Malformations. Vaderis aims to be the first company in the world to develop a medicine for HHT. Vaderis is developing an oral medicine known as VAD044 which, if successful, will both treat the symptoms of HHT and will reduce the occurrence of new lesions, thereby modifying disease progression of HHT.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vaderis TherapeuticsSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    WSJ-350 3.05, Lichtstrasse 35, 4056 Basel
    Telephone
    Telephone
    +41 79 592 20 05
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vaderis.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NEJM Publishes Vaderis' Engasertib POC/LTE Data for HHT
    NEJM Publishes Vaderis' Engasertib POC/LTE Data for HHT

    02 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vaderis-therapeutics-announces-the-new-england-journal-of-medicine-publishes-engasertib-proof-of-concept-and-long-term-extension-results-highlighting-the-therapys-potential-for-patients-with-hereditary-hemorrhagic-telangiectasia-302628280.html

    PR NEWSWIRE
    02 Dec 2025
    Share Share
    Vaderis's FDA Fast Track for VAD044 for Hereditary Telangiectasia
    Vaderis's FDA Fast Track for VAD044 for Hereditary Telangiectasia

    18 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/vaderis-receives-fda-fast-track-designation-for-vad044-for-the-treatment-of-hereditary-hemorrhagic-telangiectasia-302307357.html

    PR NEWSWIRE
    18 Nov 2024
    Share Share
    Vaderis Drug Reduces Nosebleeds In Rare Blood Vessel Disorder Trial
    Vaderis Drug Reduces Nosebleeds In Rare Blood Vessel Disorder Trial

    28 Aug 2024

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/vaderis-scores-first-win-rare-blood-vessel-disorder-drug-shown-reduce-nosebleeds

    FIERCE BIOTECH
    28 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search